Table of Content

1 Progestin Market Overview
1.1 Product Overview and Scope of Progestin
1.2 Progestin Segment by Type
1.2.1 Global Progestin Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Progestin Oral
1.2.3 Progestin Injection
1.2.4 Progestin Suspended/Gel
1.3 Progestin Segment by Application
1.3.1 Progestin Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacies & Drug Stores
1.4 Global Progestin Market Size Estimates and Forecasts
1.4.1 Global Progestin Revenue 2016-2027
1.4.2 Global Progestin Sales 2016-2027
1.4.3 Progestin Market Size by Region: 2016 Versus 2021 Versus 2027

2 Progestin Market Competition by Manufacturers
2.1 Global Progestin Sales Market Share by Manufacturers (2016-2021)
2.2 Global Progestin Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Progestin Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Progestin Manufacturing Sites, Area Served, Product Type
2.5 Progestin Market Competitive Situation and Trends
2.5.1 Progestin Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Progestin Players Market Share by Revenue
2.5.3 Global Progestin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Progestin Retrospective Market Scenario by Region
3.1 Global Progestin Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Progestin Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Progestin Market Facts & Figures by Country
3.3.1 North America Progestin Sales by Country
3.3.2 North America Progestin Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Progestin Market Facts & Figures by Country
3.4.1 Europe Progestin Sales by Country
3.4.2 Europe Progestin Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Progestin Market Facts & Figures by Region
3.5.1 Asia Pacific Progestin Sales by Region
3.5.2 Asia Pacific Progestin Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Progestin Market Facts & Figures by Country
3.6.1 Latin America Progestin Sales by Country
3.6.2 Latin America Progestin Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Progestin Market Facts & Figures by Country
3.7.1 Middle East and Africa Progestin Sales by Country
3.7.2 Middle East and Africa Progestin Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Progestin Historic Market Analysis by Type
4.1 Global Progestin Sales Market Share by Type (2016-2021)
4.2 Global Progestin Revenue Market Share by Type (2016-2021)
4.3 Global Progestin Price by Type (2016-2021)

5 Global Progestin Historic Market Analysis by Application
5.1 Global Progestin Sales Market Share by Application (2016-2021)
5.2 Global Progestin Revenue Market Share by Application (2016-2021)
5.3 Global Progestin Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Progestin Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Merck Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Teva Generics
6.2.1 Teva Generics Corporation Information
6.2.2 Teva Generics Description and Business Overview
6.2.3 Teva Generics Progestin Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Teva Generics Product Portfolio
6.2.5 Teva Generics Recent Developments/Updates
6.3 Zhejiang Xianju Pharmaceutical
6.3.1 Zhejiang Xianju Pharmaceutical Corporation Information
6.3.2 Zhejiang Xianju Pharmaceutical Description and Business Overview
6.3.3 Zhejiang Xianju Pharmaceutical Progestin Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Zhejiang Xianju Pharmaceutical Product Portfolio
6.3.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
6.4 Zhejiang Aisheng Pharmaceutical
6.4.1 Zhejiang Aisheng Pharmaceutical Corporation Information
6.4.2 Zhejiang Aisheng Pharmaceutical Description and Business Overview
6.4.3 Zhejiang Aisheng Pharmaceutical Progestin Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Zhejiang Aisheng Pharmaceutical Product Portfolio
6.4.5 Zhejiang Aisheng Pharmaceutical Recent Developments/Updates
6.5 Besins Healthcare
6.5.1 Besins Healthcare Corporation Information
6.5.2 Besins Healthcare Description and Business Overview
6.5.3 Besins Healthcare Progestin Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Besins Healthcare Product Portfolio
6.5.5 Besins Healthcare Recent Developments/Updates
6.6 Zhejiang Medicine
6.6.1 Zhejiang Medicine Corporation Information
6.6.2 Zhejiang Medicine Description and Business Overview
6.6.3 Zhejiang Medicine Progestin Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Zhejiang Medicine Product Portfolio
6.6.5 Zhejiang Medicine Recent Developments/Updates
6.7 Virtus Pharmaceuticals, LLC
6.6.1 Virtus Pharmaceuticals, LLC Corporation Information
6.6.2 Virtus Pharmaceuticals, LLC Description and Business Overview
6.6.3 Virtus Pharmaceuticals, LLC Progestin Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Virtus Pharmaceuticals, LLC Product Portfolio
6.7.5 Virtus Pharmaceuticals, LLC Recent Developments/Updates
6.8 BionPharma
6.8.1 BionPharma Corporation Information
6.8.2 BionPharma Description and Business Overview
6.8.3 BionPharma Progestin Sales, Revenue and Gross Margin (2016-2021)
6.8.4 BionPharma Product Portfolio
6.8.5 BionPharma Recent Developments/Updates

7 Progestin Manufacturing Cost Analysis
7.1 Progestin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Progestin
7.4 Progestin Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Progestin Distributors List
8.3 Progestin Customers

9 Progestin Market Dynamics
9.1 Progestin Industry Trends
9.2 Progestin Growth Drivers
9.3 Progestin Market Challenges
9.4 Progestin Market Restraints

10 Global Market Forecast
10.1 Progestin Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Progestin by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Progestin by Type (2022-2027)
10.2 Progestin Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Progestin by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Progestin by Application (2022-2027)
10.3 Progestin Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Progestin by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Progestin by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Progestin Sales (Ton) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Progestin Sales (Ton) Comparison by Application (2021-2027)
Table 3. Global Progestin Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Progestin Covered in This Study
Table 5. Global Progestin Sales (Ton) of Key Manufacturers (2016-2021)
Table 6. Global Progestin Sales Share by Manufacturers (2016-2021)
Table 7. Global Progestin Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Progestin Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Progestin Average Price (US$/Ton) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Progestin Manufacturing Sites and Area Served
Table 11. Manufacturers Progestin Product Type
Table 12. Global Progestin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Progestin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Progestin as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Progestin Sales by Region (2016-2021) & (Ton)
Table 16. Global Progestin Sales Market Share by Region (2016-2021)
Table 17. Global Progestin Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Progestin Sales by Country (2016-2021) & (Ton)
Table 19. North America Progestin Sales Market Share by Country (2016-2021)
Table 20. North America Progestin Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Progestin Revenue Market Share by Country (2016-2021)
Table 22. Europe Progestin Sales by Country (2016-2021) & (Ton)
Table 23. Europe Progestin Sales Market Share by Country (2016-2021)
Table 24. Europe Progestin Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Progestin Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Progestin Sales by Region (2016-2021) & (Ton)
Table 27. Asia Pacific Progestin Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Progestin Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Progestin Revenue Market Share by Region (2016-2021)
Table 30. Latin America Progestin Sales by Country (2016-2021) & (Ton)
Table 31. Latin America Progestin Sales Market Share by Country (2016-2021)
Table 32. Latin America Progestin Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Progestin Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Progestin Sales by Country (2016-2021) & (Ton)
Table 35. Middle East and Africa Progestin Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Progestin Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Progestin Revenue Market Share by Country (2016-2021)
Table 38. Global Progestin Sales (Ton) by Type (2016-2021)
Table 39. Global Progestin Sales Market Share by Type (2016-2021)
Table 40. Global Progestin Revenue (Million US$) by Type (2016-2021)
Table 41. Global Progestin Revenue Share by Type (2016-2021)
Table 42. Global Progestin Price (US$/Ton) by Type (2016-2021)
Table 43. Global Progestin Sales (Ton) by Application (2016-2021)
Table 44. Global Progestin Sales Market Share by Application (2016-2021)
Table 45. Global Progestin Revenue (Million US$) by Application (2016-2021)
Table 46. Global Progestin Revenue Share by Application (2016-2021)
Table 47. Global Progestin Price (US$/Ton) by Application (2016-2021)
Table 48. Merck Corporation Information
Table 49. Merck Description and Business Overview
Table 50. Merck Progestin Sales (Ton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 51. Merck Progestin Product
Table 52. Merck Recent Developments/Updates
Table 53. Teva Generics Corporation Information
Table 54. Teva Generics Description and Business Overview
Table 55. Teva Generics Progestin Sales (Ton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 56. Teva Generics Progestin Product
Table 57. Teva Generics Recent Developments/Updates
Table 58. Zhejiang Xianju Pharmaceutical Corporation Information
Table 59. Zhejiang Xianju Pharmaceutical Description and Business Overview
Table 60. Zhejiang Xianju Pharmaceutical Progestin Sales (Ton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 61. Zhejiang Xianju Pharmaceutical Progestin Product
Table 62. Zhejiang Xianju Pharmaceutical Recent Developments/Updates
Table 63. Zhejiang Aisheng Pharmaceutical Corporation Information
Table 64. Zhejiang Aisheng Pharmaceutical Description and Business Overview
Table 65. Zhejiang Aisheng Pharmaceutical Progestin Sales (Ton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 66. Zhejiang Aisheng Pharmaceutical Progestin Product
Table 67. Zhejiang Aisheng Pharmaceutical Recent Developments/Updates
Table 68. Besins Healthcare Corporation Information
Table 69. Besins Healthcare Description and Business Overview
Table 70. Besins Healthcare Progestin Sales (Ton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 71. Besins Healthcare Progestin Product
Table 72. Besins Healthcare Recent Developments/Updates
Table 73. Zhejiang Medicine Corporation Information
Table 74. Zhejiang Medicine Description and Business Overview
Table 75. Zhejiang Medicine Progestin Sales (Ton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 76. Zhejiang Medicine Progestin Product
Table 77. Zhejiang Medicine Recent Developments/Updates
Table 78. Virtus Pharmaceuticals, LLC Corporation Information
Table 79. Virtus Pharmaceuticals, LLC Description and Business Overview
Table 80. Virtus Pharmaceuticals, LLC Progestin Sales (Ton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 81. Virtus Pharmaceuticals, LLC Progestin Product
Table 82. Virtus Pharmaceuticals, LLC Recent Developments/Updates
Table 83. BionPharma Corporation Information
Table 84. BionPharma Description and Business Overview
Table 85. BionPharma Progestin Sales (Ton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 86. BionPharma Progestin Product
Table 87. BionPharma Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Progestin Distributors List
Table 91. Progestin Customers List
Table 92. Progestin Market Trends
Table 93. Progestin Growth Drivers
Table 94. Progestin Market Restraints
Table 95. Global Progestin Sales Forecast by Type (2022-2027) & (Ton)
Table 96. Global Progestin Sales Market Share Forecast by Type (2022-2027)
Table 97. Global Progestin Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 98. Global Progestin Revenue Market Share Forecast by Type (2022-2027)
Table 99. Global Progestin Sales Forecast by Application (2022-2027) & (Ton)
Table 100. Global Progestin Sales Market Share Forecast by Application (2022-2027)
Table 101. Global Progestin Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 102. Global Progestin Revenue Market Share Forecast by Application (2022-2027)
Table 103. Global Progestin Sales Forecast by Region (2022-2027) & (Ton)
Table 104. Global Progestin Sales Market Share Forecast by Region (2022-2027)
Table 105. Global Progestin Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 106. Global Progestin Revenue Market Share Forecast by Region (2022-2027)
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Progestin
Figure 2. Global Progestin Market Share by Type in 2020 & 2027
Figure 3. Progestin Oral Product Picture
Figure 4. Progestin Injection Product Picture
Figure 5. Progestin Suspended/Gel Product Picture
Figure 6. Global Progestin Market Share by Application in 2020 & 2027
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Pharmacies & Drug Stores
Figure 10. Global Progestin Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Progestin Market Size 2016-2027 (US$ Million)
Figure 12. Global Progestin Sales 2016-2027 (Ton)
Figure 13. Global Progestin Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Progestin Sales Share by Manufacturers in 2020
Figure 15. Global Progestin Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Progestin Players: Market Share by Revenue in 2020
Figure 17. Progestin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Progestin Sales Market Share by Region (2016-2021)
Figure 19. Global Progestin Sales Market Share by Region in 2020
Figure 20. Global Progestin Revenue Market Share by Region (2016-2021)
Figure 21. Global Progestin Revenue Market Share by Region in 2020
Figure 22. U.S. Progestin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Progestin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Progestin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Progestin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Progestin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Progestin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Progestin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Progestin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Progestin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Progestin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Progestin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Progestin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Progestin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Progestin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Progestin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Progestin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Progestin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Progestin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Progestin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Progestin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Progestin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Progestin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Progestin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. UAE Progestin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Progestin by Type (2016-2021)
Figure 47. Sales Market Share of Progestin by Application (2016-2021)
Figure 48. Sales Market Share of Progestin by Application in 2020
Figure 49. Revenue Share of Progestin by Application (2016-2021)
Figure 50. Revenue Share of Progestin by Application in 2020
Figure 51. Manufacturing Cost Structure of Progestin
Figure 52. Manufacturing Process Analysis of Progestin
Figure 53. Progestin Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed